In the next issue of Pharma Technology Focus, we take a look back at mumps treatments in England following reports that the number of cases in the country is set to reach heights not seen in a decade, find out what happened to the whistleblowers that spread early warnings during past epidemics, and speak to CPP development company Peptomyc about its approach to cancer treatment.
Plus, we explore ways that pharma can be reformed to help tackle the threat of climate change-related health issues, investigate the safety of inactive pharma ingredients, and ask if spin-out companies are set to become a more regular feature in pharma.
Also, we find out about a topical gene therapy that waves goodbye to needles, and take a look at a drug development playbook compiled by data analytics platform Signals Analytics.
Editor | Eloise McLennan
Group Editor | Susanne Hauner
Commissioning Editor | Daniel Garrun
Writers | Allie Nawrat, Chloe Kent
Magazine Designer | Marzia Del Gaone
Graphic Designers | Filipe Costa, Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Martina Labaiova
Lead Designer | John Hammond
Digital Publishing Director | Duncan West
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
For media partnership enquiries please contact our publishing assistant: Sophie Hoare
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Copyright 2020 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.